Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Emergence and Expansion of the SARS-CoV-2 Variant B.1.526 Identified in New York

medRxiv(2021)10.1101/2021.02.23.21252259Source: DataRank Database

Emergence and Expansion of the SARS-CoV-2 Variant B.1.526 Identified in New York is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0. It has been cited 157 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access157 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (25)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Hiroshi Mohri ORCID,Pengfei Wang ORCID,Manoj S. Nair ORCID,Jason Zucker ORCID,Zizhang Sheng ORCID

Live enrichment

PubMed:33655278 OpenAlex:https://openalex.org/W3131686432

National Institutes of Health

Grant: 1U01DA053949-01

Optimizing SARS-CoV-2 wastewater based surveillance in urban and university campus settings.

National Institutes of Health

Grant: 3UL1TR001873-07S1

Clinical and Translational Science Award

NIDA NIH HHS

Grant: U01 DA053949

NCATS NIH HHS

Grant: UL1 TR001873

Influential Citations

Citation Trend

2021

2022

2023

2024

2025

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2021/08/04/2021.02.23.21252259.full.pdf

GREENhttps://doi.org/10.1038/s41586-021-03908-2

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2021/08/04/2021.02.23.21252259.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.02.23.21252259

repositoryhttps://doi.org/10.1101/2021.02.23.21252259

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingBacillus and Francisella bacterial researchMedicine0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Lineage (genetic)VirologyAntibodyMonoclonal antibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyDominance (genetics)Transmission (telecommunications)NeutralizationCoronavirus disease 2019 (COVID-19)PandemicImmunologyGeneticsMedicineGeneInfectious disease (medical specialty)DiseaseArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Emergence and Expansion of the SARS-CoV-2 Variant B.1.526 Identified in New York

FAIR Checklist

Authors (13)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)